Monday, October 15, 2012    |    |    Archives    |   Advertising   |    CHI Conferences    |     Subscribe      



Consultant: Life Science Vendors Need a New Game Plan
eCliniqua | Life science vendors must become more strategic and price-sensitive to “stay in the game” with their clients in the trillion-dollar drug development industry, says Andreas Scherer, managing partner at consulting firm Salto Partners. The industry consensus is that drug research takes too long and has grown unsustainably expensive.  Read More 

Medidata Uses Open Chef for Clinical Development in the Cloud
eCliniqua | Medidata Solutions has deployed Opscode Hosted Chef to automate its hybrid infrastructure for clinical development: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, to clinical data capture and management, safety events capture, medical coding, and business analytics.   Read More 

Why You Should Be Adopting Adaptive Trials
eCliniqua | A special one-day conference next month will showcase many of the leading figures in the emerging field of adaptive trial designs, with a view to helping organizations recognize their benefits and understand the keys to successful implementation.  Read More  


Sanofi, Massachusetts General Hospital, Sign Trans Med Agreement
News Brief | Sanofi has announced a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors.   Read More  

DATATRAK Signs Imaging CRO Partner
News Brief |  DATATRAK International has announced that ABX-CRO, a company providing global molecular and advanced imaging services for oncology and neuroscience to the pharmaceutical and biotechnology industries, is its first imaging partner.   Read More 

Nextrials, InClin Sign Partnership
News Brief | Nextrials and InClin sign partnership to link Prism to CRO services.   Read More 

WCC Announces Endpoint Assessment Committee
News Brief | WorldCare Clinical (WCC) has announced its new Endpoint Assessment Committee (EAC) services for blinded independent central review of clinical trial data. WCC’s EAC services include expert assessments by physicians drawn from multiple therapeutic areas for comprehensive efficacy and safety reviews.  Read More 

Phase II Flub for Peregrine
Cancer Grace | A week after releasing favorable Phase II results for the novel vascular-targeting immunotherapy for non-small cell lung cancer, bavituximab, study sponsor Peregrine Pharmaceuticals has announced "major discrepancies" in the trial.   Read More 

Updated EDC for Any Research Initiative
Product Brief | The latest version of iMedNet EDC was announced today. iMedNet EDC makes electronic data capture functionality practical for any type of research initiative, even very small studies of short duration.    Read More